VTVT (STOCKS)

    vTv Therapeutics Inc. Class A Common Stock

    $30.850000
    -0.930000 (-2.93%)
    Prev close: $31.780000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Paul Jai Sekhri
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $122.93M
    Employees
    23
    P/E (TTM)
    -29.16
    P/B (TTM)
    1.59
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    3
    Strong Buy
    7
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    $-1.05 $-1.01 -0.0402 -3.98%
    Mar 2026 (Q1)
    $1.94 $-0.10 +2.0369 +2,102.06%
    Dec 2025 (Q4)
    $-0.58 $-1.11 +0.5298 +47.74%
    Sep 2025 (Q3)
    $-1.08 $-1.00 -0.0804 -8.04%
    Financial Statements
    TTM (Jun 2026)
    Revenues $36.84M
    Operating Expenses $46.09M
    Research and Development $28.68M
    Other Operating Expenses $17.41M
    Operating Income/Loss -$9.25M
    Income/Loss From Continuing Operations After Tax -$6.40M
    Income/Loss From Continuing Operations Before Tax -$6.40M
    Income Tax Expense/Benefit $0.00
    Net Income/Loss -$6.40M
    Net Income/Loss Attributable To Noncontrolling Interest -$1.65M
    Net Income/Loss Attributable To Parent -$4.76M
    Net Income/Loss Available To Common Stockholders, Basic -$4.76M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Assets $87.59M
    Current Assets $87.59M
    Prepaid Expenses $416.00K
    Other Current Assets $87.17M
    Noncurrent Assets $4.00K
    Liabilities $8.96M
    Current Liabilities $7.02M
    Noncurrent Liabilities $1.94M
    Equity $78.63M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $78.63M
    Liabilities And Equity $87.59M
    Net Cash Flow From Operating Activities -$16.76M
    Net Cash Flow From Operating Activities, Continuing -$16.76M
    Net Cash Flow From Financing Activities $77.48M
    Net Cash Flow -$2.29M
    Net Cash Flow, Continuing -$2.29M
    Comprehensive Income/Loss -$6.40M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$6.40M
    Other Comprehensive Income/Loss $0.00